Administration of GSK484 in CIA mice reduces the expression of synovial MPO, NE, and PAD4, decreases NET generation, attenuates arthritis severity, and inhibits macrophage infiltration, supporting its therapeutic potential (167). Here, PADI4 is linked to Arthritis.